Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Accuray Inc (NASDAQ:ARAY)

4.65
Delayed Data
As of Apr 21
 -0.05 / -1.06%
Today’s Change
4.45
Today|||52-Week Range
6.39
+1.09%
Year-to-Date
Is Accuray (ARAY) a Great Growth Stock?
Apr 13 / Zacks.com - Paid Partner Content
Accuray TomoTherapy System Starts Cancer Treatment in Africa
Apr 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close4.70
Today’s open4.70
Day’s range4.60 - 4.75
Volume532,318
Average volume (3 months)793,275
Market cap$385.5M
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+37.25%
Earnings growth (this year)+44.16%
Earnings growth (next 5 years)-259.10%
Revenue growth (last year)+5.00%
P/E ratioNM
Price/Sales1.05
Price/Book6.34

Competitors

 Today’s
change
Today’s
% change
VRAYViewray Inc-0.13-1.87%
AXGNAxoGen Inc-0.25-2.14%
NVDQNovadaq Technologies...-0.12-1.62%
ENTLEntellus Medical Inc-0.07-0.49%
Data as of 3:59pm ET, 04/21/2017

Financials

Next reporting dateApril 28, 2017
EPS forecast (this quarter)$0.01
Annual revenue (last year)$398.8M
Annual profit (last year)-$25.5M
Net profit margin-6.40%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joshua H. Levine
Chief Operating Officer &
Executive Vice President
Kelly J. Londy
Corporate headquarters
Sunnyvale, California

Forecasts


Search for Jobs